Literature DB >> 24663066

Pan retinal photocoagulation for proliferative diabetic retinopathy: pattern scan laser versus argon laser.

Tarek Alasil1, Nadia K Waheed.   

Abstract

PURPOSE OF REVIEW: Diabetic retinopathy is the leading cause of visual impairment in working-age adults worldwide. Pan retinal photocoagulation (PRP) has provided an effective treatment to decrease the risk of severe vision loss in patients with proliferative diabetic retinopathy for the past four decades. Pattern scan laser (PASCAL) was developed to minimize the side effects of PRP. The purpose of this review is to discuss the differences between the traditional argon laser and the PASCAL. RECENT
FINDINGS: PASCAL can achieve comparable results with the conventional argon PRP in the treatment of patients with diabetic retinopathy. The PASCAL delivery system creates well aligned arrays of retinal lesions in a shorter period. PASCAL provides amore comfortable profile when compared to the argon laser.
SUMMARY: The PASCAL is now being substituted for the conventional argon laser for PRP in many clinics. Ophthalmologists should keep in mind that adjusting the PASCAL settings (including the duration, number, and size of laser burns) might become necessary to maintain regression and eliminate recurrence of neovascularization in patients with proliferative diabetic retinopathy. Further studies are needed to determine the parameters for optimal safety and efficacy on the PASCAL.

Entities:  

Mesh:

Year:  2014        PMID: 24663066     DOI: 10.1097/ICU.0000000000000048

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  7 in total

1.  The change of macular thickness following single-session pattern scan laser panretinal photocoagulation for diabetic retinopathy.

Authors:  Jong-Hyun Oh; Seong-Woo Kim; Soon-Sun Kwon; Jaeryung Oh; Kuhl Huh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-05-27       Impact factor: 3.117

2.  Comparison of navigated laser and conventional single-spot laser system for induced pain during panretinal photocoagulation.

Authors:  Onur Polat; Sibel Inan; Zeki Baysal; Safiye Yigit; Umit Ubeyt Inan
Journal:  Lasers Med Sci       Date:  2019-11-18       Impact factor: 3.161

Review 3.  Polymyositis and dermatomyositis: ocular manifestations and potential sight-threatening complications.

Authors:  Raul E Ruiz-Lozano; Fabiola Velazquez-Valenzuela; Mariana Roman-Zamudio; Salma K Andrade-Leal; Alejandro Rodriguez-Garcia
Journal:  Rheumatol Int       Date:  2021-10-21       Impact factor: 2.631

4.  Prediction of regression of retinal neovascularisation after panretinal photocoagulation for proliferative diabetic retinopathy.

Authors:  Irini P Chatziralli; Theodoros N Sergentanis; Sobha Sivaprasad
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-01-22       Impact factor: 3.117

Review 5.  Retinal fibrosis in diabetic retinopathy.

Authors:  Sayon Roy; Shruti Amin; Sumon Roy
Journal:  Exp Eye Res       Date:  2016-01       Impact factor: 3.467

6.  Treated PDR Reveals Age-Appropriate Vision Deterioration But Distorted Retinal Organization.

Authors:  Xing D Chen; Amro Omari; Min Hwang; Leon Kwark; Natalie Dakki; Sina Farsiu; Thomas W Gardner
Journal:  Transl Vis Sci Technol       Date:  2020-02-07       Impact factor: 3.283

7.  Macular vessel density before and after panretinal photocoagulation in patients with proliferative diabetic retinopathy.

Authors:  Ahmed Shawkat Abdelhalim; Mohamed Farouk Sayed Othman Abdelkader; Mohamed Salah El-Din Mahmoud; Asmaa Anwar Mohamed Mohamed
Journal:  Int J Retina Vitreous       Date:  2022-03-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.